Matches in Wikidata for { <http://www.wikidata.org/entity/Q64645792> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q64645792 description "clinical trial" @default.
- Q64645792 description "ensayu clínicu" @default.
- Q64645792 description "klinisch onderzoek" @default.
- Q64645792 description "клінічне випробування" @default.
- Q64645792 description "կլինիկական փորձարկում" @default.
- Q64645792 name "Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes" @default.
- Q64645792 type Item @default.
- Q64645792 label "Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes" @default.
- Q64645792 prefLabel "Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 Diabetes" @default.
- Q64645792 P1132 Q64645792-005ADE21-4876-464E-8A71-97E95E0AEDD8 @default.
- Q64645792 P1476 Q64645792-D2082BBA-959C-4310-AEED-938EE77DC7FD @default.
- Q64645792 P17 Q64645792-1CF5EE8A-9CF9-470F-BCE7-1936B2DD371A @default.
- Q64645792 P17 Q64645792-5665D2FD-9DBC-4B44-A69D-5533E3FF2A83 @default.
- Q64645792 P17 Q64645792-616BEB0C-BB3D-42BB-89C3-5645D979319A @default.
- Q64645792 P17 Q64645792-63C3A604-AD7F-4F41-A838-F0563B839AB3 @default.
- Q64645792 P17 Q64645792-7A71EB79-D899-4AAA-B42A-246FDF701080 @default.
- Q64645792 P17 Q64645792-B7829BEF-2994-4424-9B5D-FA07BF93FF26 @default.
- Q64645792 P17 Q64645792-D3895AC8-9A53-4A7E-B143-57AF197B1FF1 @default.
- Q64645792 P17 Q64645792-EA060B51-248E-40A5-AF58-84DCABD099EF @default.
- Q64645792 P17 Q64645792-F193D2D8-4096-4162-B246-153167A9F272 @default.
- Q64645792 P17 Q64645792-FD688EF9-0B20-4414-BB03-CF29876E7E2B @default.
- Q64645792 P2899 Q64645792-B4EC84CE-0E07-4801-9ACF-C538688AA36E @default.
- Q64645792 P3098 Q64645792-68BFFA35-3D5D-4357-9DF0-6B4E95B20A7B @default.
- Q64645792 P31 Q64645792-26D7BB64-4066-4873-A71E-57A39432D782 @default.
- Q64645792 P4844 Q64645792-5FBEA96C-37E0-4E67-ADAA-0B8E1D3C5FB6 @default.
- Q64645792 P580 Q64645792-844ACBC7-100B-435A-A345-0778C1EBC5D8 @default.
- Q64645792 P582 Q64645792-9AA345C6-E970-47DF-A2D6-36B95B55EFB5 @default.
- Q64645792 P6099 Q64645792-FCDF98A8-14E4-4D85-BBBC-D388E1C65259 @default.
- Q64645792 P8363 Q64645792-16C69E7B-6490-4320-A27E-2760D8192722 @default.
- Q64645792 P1132 "+916" @default.
- Q64645792 P1476 "A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of TAK-875 25 mg and 50 mg Compared to Placebo and Sitagliptin 100 mg When Used in Combination With Metformin in Subjects With Type 2 Diabetes" @default.
- Q64645792 P17 Q213 @default.
- Q64645792 P17 Q214 @default.
- Q64645792 P17 Q219 @default.
- Q64645792 P17 Q224 @default.
- Q64645792 P17 Q28 @default.
- Q64645792 P17 Q30 @default.
- Q64645792 P17 Q38 @default.
- Q64645792 P17 Q408 @default.
- Q64645792 P17 Q833 @default.
- Q64645792 P17 Q869 @default.
- Q64645792 P2899 "+18" @default.
- Q64645792 P3098 "NCT01549964" @default.
- Q64645792 P31 Q30612 @default.
- Q64645792 P4844 Q19484 @default.
- Q64645792 P580 "2012-04-01T00:00:00Z" @default.
- Q64645792 P582 "2014-03-01T00:00:00Z" @default.
- Q64645792 P6099 Q42824827 @default.
- Q64645792 P8363 Q78089383 @default.